Using drugs that inhibit enzymes called CDK4/6 and CDK2 extends the G1 phase of the cell cycle and helps to slow the growth of drug-resistant breast cancer.
12don MSN
Mitotic stopwatch pathway shows how cancer loses its sense of time to avoid stress responses
When cell division (mitosis) takes too long, it can be a sign that something is wrong with the cells, for example, DNA damage ...
Morning Overview on MSN
Cancer treatment timing may matter more than you think, study says
Cancer care has long focused on what drugs to give and in what doses, but a growing body of evidence suggests the clock on ...
In 2016, Colinda Scheele, a cancer biologist at Catholic University Leuven, was studying how chemotherapy affects breast cancer cells in mice. However, she observed an inconsistency: Some cell ...
The review emphasizes how breakthroughs in understanding the molecular mechanisms of cell cycle regulation have paved the way for the development of targeted anti-cancer agents. Notably, inhibitors of ...
The U.S. Food and Drug Administration has granted regular approval to treatment with Rubraca (rucaparib) for the treatment of ...
Therapeutic cancer vaccines have experienced a remarkable resurgence over the past decade, representing a paradigm shift in oncology toward harnessing the immune system's intrinsic ability to combat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback